Skip to content
Nonprofiteer
← INTERNATIONAL VACCINE INSTITUTE

Form 990 for tax year 2023

Filed by INTERNATIONAL VACCINE INSTITUTE.

Totals

Total revenue
$96,582,480
Total expenses
$77,682,016
Contributions and grants received
$88,351,550
Grants paid
$28,723,260
Program service revenue
$0
Investment income
$1,740,857
Other revenue
$6,490,073
Total assets, end of year
$104,790,256
Total liabilities, end of year
$5,152,214
Net assets or fund balances, end of year
$99,638,042
Program services expenses (Part IX)
$64,975,772
Management and general expenses
$12,665,356
Fundraising expenses
$40,888
Program service expenses (Part III)
$64,975,772

Program services were 83.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $58,998

  • 1e · Government grants (contributions)

    $28,950,768

  • 1f · All other contributions, gifts and grants

    $59,341,784

  • 3 · Investment income

    total $1,740,857 · excluded $1,740,857

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 6d · Net rental income or loss

    total $0

  • 7d · Net gain or loss

    total $0

  • 8a · Fundraising events: gross income

    $0

  • 8a · Fundraising events: contributions included on line 1c

    $58,998

  • 8b · Fundraising events: direct expenses

    $0

  • 8c · Net income from fundraising events

    total $0 · excluded $0

  • 9a · Gaming: gross income

    $0

  • 9b · Gaming: direct expenses

    $0

  • 9c · Net income from gaming

    total $0

  • 10a · Gross sales of inventory

    $0

  • 10b · Cost of goods sold

    $0

  • 10c · Net income from sales of inventory

    total $0

  • 11a · Other revenue: FOREIGN EXCHANGE LOSS

    total -$78,912 · excluded -$78,912

  • 11b · Other revenue: RENTAL FOR RESEARCH COLLABORATION

    total $56,947 · excluded $56,947

  • 11c · Other revenue: RENTAL FOR ANIMAL ROOM

    total $41,129 · excluded $41,129

  • 11d · All other revenue

    total $6,470,909 · excluded $6,470,909

  • 11e · Other revenue, total

    $6,490,073

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,980,911 · program services $1,980,911

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $26,742,349 · program services $26,742,349

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $2,796,915 · program services $1,812,481 · management and general $984,434 · fundraising $0

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $15,335,639 · program services $10,687,904 · management and general $4,647,735 · fundraising $0

  • 8 · Pension plan contributions

    total $1,083,679 · program services $767,377 · management and general $316,302 · fundraising $0

  • 9 · Other employee benefits

    total $584,873 · program services $351,078 · management and general $233,795 · fundraising $0

  • 10 · Payroll taxes

    total $227,681 · program services $143,227 · management and general $84,454 · fundraising $0

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $137,472 · program services $30,851 · management and general $106,621 · fundraising $0

  • 11c · Fees: accounting

    total $75,376 · program services $15,127 · management and general $60,249 · fundraising $0

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $4,994,605 · program services $3,954,276 · management and general $1,040,329 · fundraising $0

  • 12 · Advertising and promotion

    total $0

  • 13 · Office expenses

    total $2,620,452 · program services $2,432,142 · management and general $188,153 · fundraising $157

  • 14 · Information technology

    total $1,140,986 · program services $648,973 · management and general $484,646 · fundraising $7,367

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $2,222,293 · program services $63,424 · management and general $2,158,869 · fundraising $0

  • 17 · Travel

    total $3,633,535 · program services $2,996,500 · management and general $636,606 · fundraising $429

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $713,184 · program services $544,600 · management and general $136,128 · fundraising $32,456

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $1,388,350 · program services $104,426 · management and general $1,283,924 · fundraising $0

  • 23 · Insurance

    total $46,613 · program services $22,869 · management and general $23,744 · fundraising $0

  • 24a · Other expenses: LAB SUPPLIES

    total $4,010,703 · program services $3,889,285 · management and general $121,418 · fundraising $0

  • 24b · Other expenses: TRAINING

    total $354,597 · program services $303,055 · management and general $51,542 · fundraising $0

  • 24c · Other expenses: REPAIRS AND MAINTENANCE

    total $85,304 · program services $12,998 · management and general $72,306 · fundraising $0

  • 24d · Other expenses: OTHER EXPENSES

    total $7,506,499 · program services $7,471,919 · management and general $34,101 · fundraising $479

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $0 · end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $54,790,470 · end of year $57,393,380

  • 3 · Pledges and grants receivable

    beginning of year $0 · end of year $0

  • 4 · Accounts receivable

    beginning of year $11,534,313 · end of year $25,510,041

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $463,818 · end of year $531,156

  • 10a · Land, buildings and equipment: cost or other basis

    $17,292,623

  • 10b · Land, buildings and equipment: accumulated depreciation

    $9,046,554

  • 10c · Land, buildings and equipment, net

    beginning of year $6,641,155 · end of year $8,246,069

  • 11 · Investments: publicly traded securities

    beginning of year $0 · end of year $0

  • 12 · Investments: other securities

    beginning of year $0 · end of year $0

  • 13 · Investments: program-related

    beginning of year $0 · end of year $0

  • 14 · Intangible assets

    beginning of year $12,659,544 · end of year $12,300,408

  • 15 · Other assets

    beginning of year $646,348 · end of year $809,202

  • 17 · Accounts payable and accrued expenses

    beginning of year $6,060,979 · end of year $5,102,041

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $51,561 · end of year $50,173

  • 27 · Net assets without donor restrictions

    beginning of year $41,002,574 · end of year $50,192,934

  • 28 · Net assets with donor restrictions

    beginning of year $39,620,534 · end of year $49,445,108

Mission and programs · 2023

Mission

SEE SCHEDULE O

Activities or mission (Part I)

TO DISCOVER, DEVELOP AND DELIVER SAFE, EFFECTIVE AND AFFORDABLE VACCINES FOR GLOBAL PUBLIC HEALTH. ITS VISION IS DEVELOPING COUNTRIES FREE OF SUFFERING FROM INFECTIOUS DISEASE.

  • The goal of the GBP510 Phase III clinical trial is to show that the immune response generated by two doses of GBP510, administered 4 weeks apart in seronegative adults aged 18 and older, is superior or non-inferior to the response produced by two doses of ChAdOx1-S (AstraZeneca). Throughout 2023, the final participant visits were completed at all 22 study sites across five countries: Thailand, the Philippines, Vietnam, New Zealand, and Ukraine. Data cleaning was also finalized in preparation for the CSR. At the same time, the booster extension (Stage II) study progressed alongside the Phase III trial, with all seven visits successfully completed at two sites in Thailand. In May 2023, SK bioscience received Marketing Authorization of COVID-19 Vaccine from UK MHRA. https://www.skbioscience.com/en/news/news_01_01?mode=view&id=212& (30May2023)

    Expenses $12,830,839 · Grants $7,280,313

  • VAT0008 is a pivotal multi-country phase 3, multi-stage, modified double-blind and multi-arm study where efficacy, safety and immunogenicity of two SARS-CoV-2 adjuvanted recombinant protein vaccines (monovalent and bivalent) were tested as primary series and monovalent booster dose as an extension. IVI led the effort in Nepal to conduct the clinical trial including conducting the local DSMB meeting. The primary series study was initiated in July 2021. The first subject for the primary series was enrolled in September 2021. The crossover/booster phase started in January 2023. The last subject vaccination for the crossover/booster phase was completed in November 2023. Investigators Meeting was conducted in February 2023 for the successful conduction of the primary series study. The 11th DSMB meeting was held on September 2023, and no safety concern was raised. IVI team conducted a Quality Control visit in Q3 2023.

    Expenses $2,168,101 · Grants $1,449,309

  • In 2023, the GCCDP team performed additional testing of a subgroup in Phase II samples at Nexelis laboratory in Canada after discussion with CEPI. Nexelis was chosen as the new central laboratory for all immunogenicity testing, following the decision to shift primary laboratory assay to micro-PRNT. The 3rd DSMB meeting was held in May 2023 upon completion all visits from Phase II, and DSMB endorsed the continuation of the studies as planned. Based on additional testing results of days 28 and 56 of Phase II subgroup samples, data from non-human primate (NHP) passive transfer study and safety data, a final decision on the optimal dose was made to 40 ug. A consortium consensus justification memo for final dose selection completed. Protocol Amendment V 5.0 containing this new information was approved by local Ethical Committees and NRAs. In Sep 2023, the proposal for expanding the program was submitted to CEPI to conduct the studies to assess the long-term safety, durability of protection and a measurement of vaccine effectiveness in Chikungunya virus endemic countries for the candidate CHIKV vaccine.

    Expenses $1,717,072 · Grants $907,882

  • ALL OTHER PROGRAMS

    Expenses $48,259,760 · Grants $19,085,756

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • JEROME KIM

    DIRECTOR GENERAL

    Total calculated
    $879,626
    From this org
    $730,385
    From related orgs
    $0
    Other
    $149,241
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $385,911
    Bonus
    $66,915
    Other
    $277,559
    Deferred
    $148,500
    Nontaxable benefits
    $741
    Filer's total
    $879,626
  • FRANCOIS BELIN

    CHIEF OPERATING OFFICER

    Total calculated
    $480,184
    From this org
    $476,690
    From related orgs
    $0
    Other
    $3,494
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $349,858
    Bonus
    $0
    Other
    $126,832
    Deferred
    $0
    Nontaxable benefits
    $3,494
    Filer's total
    $480,184
  • FLORIAN MARKS

    DEPUTY DIR. GEN, EPIDEMIOLOGY

    Total calculated
    $324,004
    From this org
    $322,094
    From related orgs
    $0
    Other
    $1,910
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $258,628
    Bonus
    $0
    Other
    $63,466
    Deferred
    $0
    Nontaxable benefits
    $1,910
    Filer's total
    $324,004
  • ANH WARTEL

    DEPUTY DIR. GEN, EUROPE

    Total calculated
    $317,561
    From this org
    $315,282
    From related orgs
    $0
    Other
    $2,279
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $244,330
    Bonus
    $0
    Other
    $70,952
    Deferred
    $0
    Nontaxable benefits
    $2,279
    Filer's total
    $317,561
  • SUSHANT SAHASTRABUDDHE

    ASSOCIATE DIRECTOR GENERAL

    Total calculated
    $304,769
    From this org
    $301,836
    From related orgs
    $0
    Other
    $2,933
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $187,803
    Bonus
    $0
    Other
    $114,033
    Deferred
    $0
    Nontaxable benefits
    $2,933
    Filer's total
    $304,769
  • JULIA LYNCH

    PROGRAM DIRECTOR, CHOLERA

    Total calculated
    $302,628
    From this org
    $286,139
    From related orgs
    $0
    Other
    $16,489
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $242,846
    Bonus
    $0
    Other
    $43,293
    Deferred
    $0
    Nontaxable benefits
    $16,489
    Filer's total
    $302,628
  • JOHN D CLEMENS

    SENIOR SCIENTIFIC ADVISOR

    Total calculated
    $299,796
    From this org
    $258,979
    From related orgs
    $0
    Other
    $40,817
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $241,041
    Bonus
    $0
    Other
    $17,938
    Deferred
    $40,000
    Nontaxable benefits
    $817
    Filer's total
    $299,796
  • MANKI SONG

    DEPUTY DIR. GENERAL, SCIENCE

    Total calculated
    $287,882
    From this org
    $284,147
    From related orgs
    $0
    Other
    $3,735
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $229,156
    Bonus
    $0
    Other
    $54,991
    Deferred
    $2,365
    Nontaxable benefits
    $1,370
    Filer's total
    $287,882
  • Tobin Guarnacci

    Global Head, Quality Mgmt

    Total calculated
    $277,954
    From this org
    $253,255
    From related orgs
    $0
    Other
    $24,699
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $181,788
    Bonus
    $0
    Other
    $71,467
    Deferred
    $20,000
    Nontaxable benefits
    $4,699
    Filer's total
    $277,954
  • Vincent Canouet

    DEPUTY DIR. GEN, Strategy

    Total calculated
    $253,441
    From this org
    $252,723
    From related orgs
    $0
    Other
    $718
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $188,975
    Bonus
    $0
    Other
    $63,748
    Deferred
    $0
    Nontaxable benefits
    $718
    Filer's total
    $253,441
  • Kyung-Taik Han

    DEPUTY DIR. GEN, Gov. Relation

    Total calculated
    $240,217
    From this org
    $239,087
    From related orgs
    $0
    Other
    $1,130
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $196,116
    Bonus
    $0
    Other
    $42,971
    Deferred
    $0
    Nontaxable benefits
    $1,130
    Filer's total
    $240,217
  • Jean-Louis Excler

    Program Dir., New Initiatives

    Total calculated
    $218,612
    From this org
    $218,092
    From related orgs
    $0
    Other
    $520
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $218,092
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $520
    Filer's total
    $218,612
  • GEORGE BICKERSTAFF

    CHAIRPERSON / BOARD OF TRUSTEE

    Total calculated
    $1,500
    From this org
    $1,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • HANNAH NOHYNEK

    VICE-CHAIRPERSON/BOARD TRUSTEE

    Total calculated
    $1,500
    From this org
    $1,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • MALCOLM SWEENEY THRU 1123

    TREASURER / BOARD OF TRUSTEE

    Total calculated
    $1,500
    From this org
    $1,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • ZIAD AHMED A MEMISH

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,500
    From this org
    $1,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • MELANIE SAVILLE

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,500
    From this org
    $1,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • RALF CLEMENS

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,250
    From this org
    $1,250
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • ANTHONY FORD-HUTCHINSON

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,250
    From this org
    $1,250
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • JEAN-MARIE OKWO-BELE

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,000
    From this org
    $1,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • CHRIS VARMA thru 1123

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $1,000
    From this org
    $1,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • YANCHUN LILY LI as of 1123

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $750
    From this org
    $750
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • RICHARD HENRIQUESas of 1123

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $750
    From this org
    $750
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • GORDON DOUGAN

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $500
    From this org
    $500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1
  • RAJIV BAHL

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Jos R-Estupian THRU 1023

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • EHSANUL KABIR

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • JOO-YOEN KANG

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Takeshi Kasai thru 0323

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • OUTI KUIVASNIEMI

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • LEON MUTESA

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • NAKORN PREMSRI

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • GI-EUN RHIE

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • KIM SUNG SOON THRU 0323

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • CATHARINA MAIJGREN STEFFENSSO

    DIRECTOR / BOARD OF TRUSTEE

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Travel for companions
  • 1a · Tax indemnification and gross-up payments
  • 1a · Housing allowance or residence for personal use
  • 1a · Personal services (maid, chauffeur, chef)
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

SCHEDULE J, PART I, LINE 1A:
TRAVEL FOR COMPANION: AFTER 15 MONTHS OF SERVICE, THE INTERNATIONALLY RECRUITED STAFF IS ENTITLED TO HOME LEAVE TRAVEL. THIS ENTITLEMENT IS AN ECONOMY ROUND TRIP BETWEEN DUTY STATION AND HOME BASE FOR STAFF, SPOUSE AND DEPENDENTS UNDER 21. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: IN ORDER TO EQUALIZE THE BENEFITS ACCRUED TO INTERNATIONALLY RECRUITED STAFF, IVI COMPENSATES STAFF WHO ARE OBLIGATED TO PAY TAXES ON IVI DERIVED INCOME TO THEIR HOME COUNTRY. ANY TAX SUBSEQUENTLY LEVIED ON THE AMOUNT OF THE REIMBURSEMENT IS NOT REIMBURSED. IN GENERAL, THIS IS TREATED AS TAXABLE COMPENSATION. HOUSING ALLOWANCE: IVI PROVIDES INTERNATIONALLY RECRUITED STAFF IN KOREA WITH A HOUSING ALLOWANCE UP TO 75% OF A CEILING THAT IS ESTABLISHED AND REVIEWED PERIODICALLY. PERSONAL SERVICES (I.E. DRIVER): IVI PROVIDES THE DIRECTOR GENERAL WITH A DRIVER WHICH IS INCLUDED IN HIS/HER EMPLOYMENT CONTRACT PACKAGE APPROVED BY THE BOARD OF TRUSTEES.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

  • Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program Service Program

  • EdJen BioTech LLC

    $235,000

  • SAIL FOR HEALTH LLC

    $193,108

  • Levin & Morgan LLC (Ann Levin)

    $20,000

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type
form_990
Tax year
2023
Filed
8 November 2024
IRS schema version
2023v5.1
Source object
202433179349304258

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.